FDA approves first absorbable stent for coronary artery disease
The U.S. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease. The Absorb GT1 Bioresorbable Vascular Scaffold System (BVS), which releases the...
View ArticleBiotech execs in search of human guinea pigs find eager subjects: themselves
When physicist Alex Zhavoronkov looked in the mirror one day and saw alarming swelling around his eyes, he guessed it was an allergic reaction to a drug he’d taken. But he couldn’t just ring up his...
View ArticleFDA approves Differin Gel 0.1% for over-the-counter use to treat acne
The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is approved for use in...
View ArticleDaniel Mucida, who studies the guts specialized immune system, receives...
Daniel Mucida’s research focuses on how the intestinal immune system balances vigilance to threats with tolerance to harmless foreign proteins. read more
View ArticleVariants of vespid venom
Translate to en:] Eine bedrohliche Situation für Allergiker: Wer auf Wespen falsch reagiert oder schlicht unvorsichtig ist, wird schnell gestochen. read more
View ArticleLobbyists For EpiPen Maker Included Former Clinton and McConnell Aides
Records show that Mylan spent more than $2 million on Washington lobbying in 2015. read more
View ArticleIntestinal bacteria influence food allergies
The intestinal microbiota (shown here is a histological staining of a colon section) is significantly influencing the immune system of the host. read more
View ArticleFDA approves expanded indications for Ilaris for three rare diseases
The U.S. Food and Drug Administration today approved three new indications for Ilaris (canakinumab). read more
View ArticleFreeze-dried plasma to the rescue
Since hemorrhage is the leading cause of preventable death in combat casualties, Air Force Special Operations Command is improving access to blood products on the battlefield.Freeze-dried plasma is one...
View ArticleKmart Pharmacy Lowers Cost of Generic Epinephrine Auto-injector Pens
HOFFMAN ESTATES, Ill., April 25, 2017 / / -- In response to the massive increase in the cost of epinephrine auto-injector pens, Kmart Pharmacy lowered the cost of the generic version of Adrenaclick...
View ArticleIngestible drug-delivery materials may help patients comply with treatment...
Jinyao Liu, left, and Giovanni Traverso stretch a new hydrogel. To help ensure patients receive their full course of treatment, researchers have developed a new set of drug delivery materials made of...
View ArticleShingrix approved in the US for prevention of shingles in adults aged 50 and...
GlaxoSmithKline plc [LSE/NYSE: GSK] today announced that the US Food and Drug Administration (FDA) has approved Shingrix (Zoster Vaccine Recombinant, Adjuvanted) for the prevention of shingles (herpes...
View ArticleCDCs Advisory Committee on Immunization Practices recommends Shingrix as the...
Herpes Zoster subunit vaccine (Shingrix) is recommended for the prevention of herpes zoster and related complications for immunocompetent adults aged 50 years and older. read more
View ArticleNIAID scientists link cases of unexplained anaphylaxis to red meat allergy
Tick bites likely lead to the unusual, misdiagnosed allergy. read more
View ArticleGenentech to Present Five-Year OCREVUS (Ocrelizumab) Efficacy and Safety Data...
Data reinforce importance of early initiation and continuation of OCREVUS treatment New analyses highlight the need for active treatment in underrepresented populations, such as primary progressive MS...
View ArticleAAP Applauds Passage of Bill That Will Keep Children Safe During Air Travel
The Federal Aviation Administration (FAA) reauthorization, on its way to the president for signature into law, includes the bipartisan Airplane Kids in Transit Safety (KiTS) Act, a long-time priority...
View ArticleMore Than 30 Data Presentations from Sanofi Genzymes Multiple Sclerosis...
Additional Courses of Alemtuzumab Improved Clinical and MRI Outcomes in Pooled CARE-MS I and II Patients With Disease Activity After Three Courses: Analysis of Patients Who Received ≥4 Courses (Poster...
View ArticleOCREVUS (Ocrelizumab) Data Show Early Initiation of Treatment Reduces...
People with relapsing MS (RMS) treated sooner with OCREVUS had earlier reduction in disease activity and less disability progression vs.read more
View ArticleSanofi presents new data on Aubagio (teriflunomide)
CAMBRIDGE, Mass.--( )--Aubagio® (teriflunomide) significantly slowed whole brain volume loss (atrophy) compared with placebo in patients with a first clinical episode suggestive of multiple sclerosis...
View Article
